FIELD: pharmacology.
SUBSTANCE: new formula 
(I) compounds are prepared, as well as their complexes, which can be used to prepare a pharmaceutical composition for prevention and treatment of strontium, tin or lead poisoning.
EFFECT: increased application effeciency.
13 cl, 9 tbl, 18 ex, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SYNTHESIS OF 1,4,10,13-TETRAOXA-7,16-DIAZACYCLOOCTADECANE-N,N'-DIMALONIC ACID SALT | 1990 |
|
RU2072993C1 |
| FLUORESCENT CONTRASTING NEAR INFRARED AGENT AND METHOD OF FLUORESCENT TOMOGRAPHY | 2003 |
|
RU2350355C9 |
| DIPEPTIDE, CONTAINING NONPROTEINOGENIC AMINO ACID | 2012 |
|
RU2643515C2 |
| PYRIDINE DERIVATIVE | 2013 |
|
RU2640588C2 |
| DERIVATIVES OF BIPHENYLAMIDINE | 1998 |
|
RU2197478C2 |
| NEW GADOLINIUM CHELATE COMPOUNDS WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING | 2017 |
|
RU2755181C2 |
| BENZOTHIADIAZEPINE DERIVATIVES AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2002 |
|
RU2305681C2 |
| METHOD OF SYNTHESISING SULFONYLHALOGENIDES AND SULFONAMIDES FROM SALTS OF SULFONIC ACIDS | 2006 |
|
RU2466983C2 |
| NOVEL DERIVATIVES OF ACETAMIDE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND PROTEASE INHIBITORS BASED ON THEREOF | 1997 |
|
RU2181360C2 |
| INHIBITORS OF FACTOR VIIA | 2000 |
|
RU2248359C2 |
